T2356

RO-3306 is a selectivity ATP-competitive CDK1 inhibitor (Ki: 20 nM). The selectivity of RO-3306 for CDK1 is >15-fold higher than a diverse panel of human kinases.

5-HT re-uptake inhibitor

benzodiazepine receptor antagonist,competitive

Zolantidine dimaleate represents the first-in-class, brain-penetrating histamine H2 receptor antagonist cross the blood-brain barrier with high efficiency to modulate histaminergic signaling within the central nervous system during various preclinical experimental protocols.

Sodium-hydrogen exchanger isoform 1 (NHE1) inhibitor

Zonisamide sodium is a 1,2 benzisoxazole derivative. It is the first agent of this chemical class to be developed as an antiepileptic drug.

fluorescent ligand that binds to the α4β1 integrin (VLA-4)